Velodyne Lidar and Trunk.Tech Announce Strategic Partnership in Autonomous Trucking
Velodyne Lidar, Inc. (Nasdaq: VLDR, VLDRW) today announced a strategic partnership with Beijing Trunk Technology Co., Ltd. (Trunk.Tech). The companies will collaborate in developing next-generation autonomous heavy trucks and to accelerate commercialization of driverless trucks in China’s logistics market.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210119005243/en/
Velodyne Lidar and Trunk.Tech will collaborate in developing next-generation autonomous heavy trucks and to accelerate commercialization of driverless trucks in China’s logistics market. (Photo: Trunk.Tech)
Velodyne and Trunk.Tech will cooperate on lidar-enabled products that meet the demanding requirements of high-speed transportation logistics. These solutions will strengthen object awareness and detection capabilities of unmanned heavy trucks and are designed to promote rapid, large-scale vehicle production in a cost-effective, efficient way. Trunk.Tech has close cooperation with commercial vehicle OEMs to produce driverless trucks and ensure the vehicles comply with vehicle safety regulations.
Trunk.Tech is the first company in China to independently develop SAE Level 4 driverless trucks, based on its own powerful driverless hardware and software systems. It uses Velodyne’s lidar, including Ultra Puck™, Puck™ and Velarray H800 sensors, as core sensor hardware in its autonomous trucks. Trunk.Tech selected Velodyne due to sensor quality, performance and mass production capacity.
“Autonomous trucks can supplement labor gaps, save fuel costs and enhance logistics, as well as improve transportation safety and help reduce truck accident rates,” said Dr. Zhang TianLei, CEO, Trunk.Tech. “Velodyne sensors, combined with our multi-sensor fusion algorithms, enable trucks to achieve high-precision, long-range real-time sensing to support autonomous driving on complex road environments. Velodyne has the expertise and manufacturing scale to help us transform trucking and our companies share a strong focus on vehicle safety.”
“Trunk.Tech is leading the industry in demonstrating how autonomous vehicle technology, powered by lidar, is bringing major efficiency and safety advances to trucking,” said Anand Gopalan, Chief Executive Officer, Velodyne Lidar. “We look forward to working closely with Trunk.Tech on creating next-generation autonomous driving solutions that dramatically improve how goods and materials move in logistics networks.”
Trunk.Tech: Deep Experience in Autonomous Trucking
In the last few years, Trunk.Tech has deployed Velodyne lidar sensors on dozens of driverless trucks that have been delivered to commercial customers. Currently, these vehicles are operating autonomously at ports in China on a 24/7/365 basis to support operations.
Since winning China’s first commercial road test license in 2018, Trunk.Tech driverless trucks have carried out a large number of practical road tests on China roadways. It completed the country’s first high-speed test for fully autonomous driving. In 2019, Trunk.Tech won key national research and development program projects, becoming the first driverless technology company to receive right-of-way support.
Trunk.Tech is actively building a broad intelligent logistics ecosystem to support autonomous trucking in China. The ecosystem includes Trunk.Tech and Bosch Group at the driverless truck terminal. It also includes strategic partners China Heavy Automobile, Uberco, Ulse Automotive and Geely Commercial Vehicles for collaboration to promote mass production.
About Velodyne Lidar
Velodyne Lidar (Nasdaq: VLDR, VLDRW) ushered in a new era of autonomous technology with the invention of real-time surround view lidar sensors. Velodyne is the first public pure-play lidar company and is known worldwide for its broad portfolio of breakthrough lidar technologies. Velodyne’s revolutionary sensor and software solutions provide flexibility, quality and performance to meet the needs of a wide range of industries, including autonomous vehicles, advanced driver assistance systems (ADAS), robotics, unmanned aerial vehicles (UAV), smart cities and security. Through continuous innovation, Velodyne strives to transform lives and communities by advancing safer mobility for all. For more information, visit www.velodynelidar.com.
Forward Looking Statements
This press release contains "forward looking statements" within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995 including, without limitation, all statements other than historical fact and include, without limitation, statements regarding Velodyne’s target markets, new products, development efforts, competition. When used in this press release, the words "estimates," "projected," "expects," "anticipates," "forecasts," "plans," "intends," "believes," "seeks," "may," "will," “can,” "should," "future," "propose" and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements are not guarantees of future performance, conditions or results and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside Velodyne's control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. Important factors, among others, that may affect actual results or outcomes include the uncertain impact of the COVID-19 pandemic on Velodyne's and its customers' businesses; Velodyne's ability to manage growth; Velodyne's ability to execute its business plan; uncertainties related to the ability of Velodyne's customers to commercialize their products and the ultimate market acceptance of these products; uncertainties related to Velodyne's estimates of the size of the markets for its products; uncertainties regarding government regulation and adoption of lidar for pedestrian safety, traffic congestion and smart city applications; the rate and degree of market acceptance of Velodyne's products; the success of other competing lidar and sensor-related products and services that exist or may become available; Velodyne's ability to identify and integrate acquisitions; uncertainties related to Velodyne's current litigation and potential litigation involving Velodyne or the validity or enforceability of Velodyne's intellectual property; and general economic and market conditions impacting demand for Velodyne's products and services. Velodyne undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
Chief Financial Officer
Landis Communications Inc.
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
South Africa and France Lead the Way in Public and Private Sector Gender Diversity, Latest Research by Kearney Reveals2.3.2021 15:00:00 CET | Press release
The latest ‘Gender Equality Report’ from Kearney has revealed progress in the representation of women in both public and private sectors, but the figures still don’t show parity. Ahead of International Women’s Day, the analysis provides insight into the progress of gender diversity in private and public sectors across nine countries – the United States, United Kingdom, Australia, India, France, Spain, Germany, South Africa and Singapore. The annual report revealed that France was number one for representation in the private sector with women comprising nearly 44% (43.8%) of board members on average, however only 2% of these women held top board positions. The UK (36%) and Australia (34%) also scored highly for representation of women on boards. The average for board level representation of women is 29.9% - not even one in three. % Female board level representation by country France 43.8% UK 36.0% Australia 34.0% Germany 32.5% Spain 29.8% US 29.8% South Africa 28.5% Singapore 17.3% Indi
beqom Announces beqom FlexFS, a Compensation Management Solution Dedicated to Financial Services2.3.2021 15:00:00 CET | Press release
beqom, provider of cloud-based compensation management software, today announced the launch of beqom FlexFS, a solution designed specifically for the financial services (FS) industry. “Financial services compensation is unique,” says Vismay Gada, Head of North America and Global Financial Services at beqom. “First there is a broad spectrum of financial services companies—retail banking, investment banking, asset management, hedge funds, insurance, private equity, and so on. That means that rewards and deferred compensation structures have many specialized needs across the industry. And, companies in each segment have to deal with different regulations that impact compensation treatment, which has its own unique challenges. Our FS customers have come to us to help them address complex compensation requirements that are beyond the scope of what their core HR systems can handle.” “We usually see a lot of our FS companies use Excel or Access databases to augment the limitations of core HR
Craig Lipset is Appointed Chairman of the Trialbee Industry Advisory Board2.3.2021 15:00:00 CET | Press release
Trialbee, the leading global data and technology platform provider for patient matching and enrollment in clinical trials, today announced the appointment of Craig Lipset as Chairman of the Trialbee Industry Advisory Board. Craig is a recognized visionary leader who has spent his career dedicated to transforming some of the most challenging issues in clinical research through new innovations. Craig is the former Head of Clinical Innovation and Venture Partner at Pfizer and a distinguished leader at the forefront of innovation in clinical research and medicine development. Most recently Craig cofounded and co-Chairs the Decentralized Trials & Research Alliance (DTRA), which roughly 100 leading life science organizations have joined the first few months since it was established. The core mission of DTRA is making clinical trial participation widely accessible by advancing policies, research practices and new technologies in decentralized clinical research. A significant barrier to patien
Maana and Aramco Trading Company Launch AI Application to Optimize Maritime Fleet and Shipping Operations2.3.2021 15:00:00 CET | Press release
Aramco Trading Company (ATC) and Maana today announced the launch of Fanar, the first Artificial Intelligence (AI)-driven maritime fleet optimization application on Microsoft Azure purpose-built for the oil and gas industry. Fanar combines the expertise of ATC and the Maana Q knowledge technology. It unifies maritime fleet optimization, planning, management and shipment scheduling on a single platform. The application: systematically integrates all data sources, constraints, and business rules automatically optimizes schedules across the fleet with a single click rapidly processes “what if” scenarios for better insights dynamically incorporates historic performance to generate new predictions Fanar has been tested daily by ATC since June 2020. “Collaboration between Maana and Microsoft helps us, through Fanar, to drive down costs,” said Ibrahim Q. Al Buainain, President and CEO of Aramco Trading Company. “Fanar enables us to optimize all local decisions across our maritime shipping and
PierianDx Announces the Appointment of Lindsay Mateo as Chief Business Officer2.3.2021 15:00:00 CET | Press release
PierianDx, the global leader in clinical genomics knowledge, today announced the appointment of Lindsay Mateo as Chief Business Officer, effective immediately. In her new role, Ms. Mateo will reinforce the company’s position as the leading provider of clinical genomics solutions in the fight against cancer and hereditary disease. She will also head the company’s life sciences efforts, establishing key alliances with industry partners and biopharmaceutical companies that will ultimately provide broader access to genomic testing and precision medicine-based treatments for patients. Ms. Mateo is an experienced executive with a history of building world-class teams, devising successful commercial strategies, and building partnerships within the diagnostics industry. Prior to joining PierianDx, she served as Head of Commercial Operations and later as VP, Head of Life Sciences at Tempus. She has also led commercial teams at NAVICAN, an Intermountain Healthcare Company, focused on precision m
Kymeta and Blue Edge Global Strategic Partnership Delivers Real World SATCOM Field Training with Military Trained Specialists2.3.2021 15:00:00 CET | Press release
Kymeta (www.kymetacorp.com), the communications company making mobile global, announced today a new premier training partnership with Blue Edge Global, a privately owned and operated, certified Service-Disabled Veteran Owned Small Business. The partnership is designed to provide instructor-led responsive training solutions for land, air, sea, and space domains where uninterrupted communications are required to enable high risk missions, first responder arrive-ready solutions and where natural or other disasters require immediate logistical support. Together, Kymeta and Blue Edge Global will offer downrange training with a team of military SATCOM specialists to the Department of Defense (DoD), Ministry of Defense (MoD) and Emergency Services teams globally. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210302005134/en/ Military specialist attends advanced SATCOM training. (Photo: Business Wire) The collaboration with Blue Ed
Guardant360 ® CDx Liquid Biopsy CE-Marked for Comprehensive Tumor Mutation Profiling Across All Solid Cancers2.3.2021 14:05:00 CET | Press release
Guardant Health, Inc. (Nasdaq: GH) has CE-marked Guardant360® CDx for tumor mutation profiling, also known as comprehensive genomic profiling (CGP), in patients with any solid malignant neoplasm (cancerous tumor). The test is also approved as a companion diagnostic to identify non-small cell lung cancer patients with epidermal growth factor receptor (EGFR)alterations who may benefit from treatment with Tagrisso® (osimertinib). The Guardant360 CDx test offers patients and clinicians a simple, faster blood test to help inform personalized treatment options. The Guardant360 CDx received U.S. FDA approval in August 2020. “Gaining the CE-mark for our Guardant360 CDx test is an important step to making our test more widely accessible to patients around the world. We are committed to helping cancer patients be comprehensively tested to see if they are appropriate for potentially life-changing personalized treatments,” said Helmy Eltoukhy, Guardant Health CEO. The World Health Organization est
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom